The distinct role of T cell costimulation in antiviral immunity

Current Opinion in Virology

Volumn 3, Issue 4, 2013, Pages 475-482

  Welten, Suzanne P M ^a   Melief, Cornelis J M ^b   Arens, Ramon ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ISA Therapeutics BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD70 ANTIGEN; CD8 ANTIGEN; OX40 LIGAND;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; INFLUENZA VIRUS A; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS REPLICATION;

EID: 84885036208     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.06.012     Document Type: Review

References (70)

1. Arens R, Schoenberger SP: Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 2010, 235:190-205.
2. Virgin HW, Wherry EJ, Ahmed R: Redefining chronic viral infection. Cell 2009, 138:30-50.
3. O'Hara GA, Welten SP, Klenerman P, Arens R: Memory T cell inflation: understanding cause and effect. Trends Immunol 2012, 33:84-90.
4. Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126. (Pubitemid 37323235)
5. Croft M: The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009, 9:271-285.
6. Bertram EM, Tafuri A, Shahinian A, Chan VS, Hunziker L, Recher M, Ohashi PS, Mak TW, Watts TH: Role of ICOS versus CD28 in antiviral immunity. Eur J Immunol 2002, 32:3376-3385. (Pubitemid 36024375)
7. McAdam AJ, Farkash EA, Gewurz BE, Sharpe AH: B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol 2000, 74:203-208. (Pubitemid 30002899)
8. Fuse S, Obar JJ, Bellfy S, Leung EK, Zhang W, Usherwood EJ: CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. J Virol 2006, 80:9159-9170. (Pubitemid 44359988)
9. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD: Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol 2011, 186:4599-4608.
10. Fuse S, Zhang W, Usherwood EJ: Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol 2008, 180:1148-1157.
11. Duttagupta PA, Boesteanu AC, Katsikis PD: Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 2009, 29:469-486.
12. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28- deficient mice. Science 1993, 261:609-612. (Pubitemid 23278372)
13. Boesteanu AC, Katsikis PD: Memory T cells need CD28 costimulation to remember. Semin Immunol 2009, 21:69-77.
14. Eberlein J, Davenport B, Nguyen TT, Victorino F, Sparwasser T, Homann D: Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity. J Virol 2012, 86:1955-1970.
15. Grujic M, Bartholdy C, Remy M, Pinschewer DD, Christensen JP, Thomsen AR: The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus. J Immunol 2010, 185:1730-1743.
16. Lee BJ, Reiter SK, Anderson M, Sarawar SR: CD28(S/S) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68. J Virol 2002, 76:3049-3053. (Pubitemid 34184891)
17. Lyon AB, Sarawar SR: Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68. Virology 2006, 356:50-56. (Pubitemid 44750039)
18. Arens R, Loewendorf A, Redeker A, Sierro S, Boon L, Klenerman P, Benedict CA, Schoenberger SP: Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations. J Immunol 2011, 186:3874-3881.
19. Bertram EM, Dawicki W, Watts TH: Role of T cell costimulation in anti-viral immunity. Semin Immunol 2004, 16:185-196. (Pubitemid 38569899)
20. Arens R, Loewendorf A, Her MJ, Schneider-Ohrum K, Shellam GR, Janssen E, Ware CF, Schoenberger SP, Benedict CA: B7- mediated costimulation of CD4 T cells constrains cytomegalovirus persistence. J Virol 2011, 85:390-396.
21. Moore TV, Clay BS, Ferreira CM, Williams JW, Rogozinska M, Cannon JL, Shilling RA, Marzo AL, Sperling AI: Protective effector memory CD4 T cells depend on ICOS for survival. PLoS ONE 2011, 6:e16529.
22. Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, Gallimore A, Gutierrez-Ramos JC, Bachmann MF: Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000, 192:53-61. (Pubitemid 30470806)
23. Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, Monticelli L, Lao C, Crotty S: ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011, 34:932-946.
24. Schildknecht A, Miescher I, Yagita H, van den Broek M: Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur J Immunol 2007, 37:716-728. (Pubitemid 46916938)
25. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J: CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000, 1:433-440.
26. van Gisbergen KP, Klarenbeek PL, Kragten NA, Unger PP, Nieuwenhuis MB, Wensveen FM, ten BA, Tak PP, Eldering E, Nolte MA, van Lier RA.
27. Munitic I, Kuka M, Allam A, Scoville JP, Ashwell JD: CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. J Immunol 2013, 190:1169-1179.
28. Penaloza-Macmaster P, Rasheed AU, Iyer SS, Yagita H, Blazar BR, Ahmed R: Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice. J Virol 2011, 85:6168-6174.
29. van Montfrans JM, Hoepelman AI, Otto S, van GM, van de Corp, de Weger RA, Monaco-Shawver L, Banerjee PP, Sanders EA, Jol-van der Zijde CM et al.: CD27 deficiency is associated withcombined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129:787-793.
30. Salzer E, Daschkey S, Choo S, Gombert M, Santos-Valente E, Ginzel S, Schwendinger M, Haas OA, Fritsch G, Pickl WF et al.: Combined immunodeficiency with life-threatening EBVassociated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2013, 98:473-478.
31. Welten SP, Redeker A, Franken KL, Benedict CA, Yagita H, Wensveen FM, Borst J, Melief CJ, van Lier RA, van Gisbergen KP, Arens R: CD27/CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J Virol 2013, 87:6851-6865.
32. Matter M, Odermatt B, Yagita H, Nuoffer JM, Ochsenbein AF: Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med 2006, 203:2145-2155. (Pubitemid 44352235)
33. Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, Borst J, van Oers MH, van Lier RA: Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003, 4:49-54. (Pubitemid 36104708)
34. Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B, Odermatt B, Bachmann MF: OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999, 11:699-708. (Pubitemid 30030709)
35. Hendriks J, Xiao Y, Rossen JW, van der Sluijs KF, Sugamura K, Ishii N, Borst J: During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J Immunol 2005, 175:1665-1676. (Pubitemid 41023070)
36. Salek-Ardakani S, Flynn R, Arens R, Yagita H, Smith GL, Borst J, Schoenberger SP, Croft M: The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Invest 2011, 121:296-307.
37. Salek-Ardakani S, Moutaftsi M, Crotty S, Sette A, Croft M: OX40 drives protective vaccinia virus-specific CD8 T cells. J Immunol 2008, 181:7969-7976.
38. Humphreys IR, Loewendorf A, De TC, Schneider K, Benedict CA, Munks MW, Ware CF, Croft M: OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T cells: A CD4- dependent mechanism. J Immunol 2007, 179:2195-2202.
39. Boettler T, Moeckel F, Cheng Y, Heeg M, Salek-Ardakani S, Crotty S, Croft M, von Herrath MG: OX40 facilitates control of a persistent virus infection. PLoS Pathog 2012, 8:e1002913.
40. Lin GH, Sedgmen BJ, Moraes TJ, Snell LM, Topham DJ, Watts TH: Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J Immunol 2009, 182:934-947.
41. Wang C, Lin GH, McPherson AJ, Watts TH: Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 2009, 229:192-215.
42. Zhao Y, Croft M: Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells. Immunol Lett 2012, 141:220-226.
43. Humphreys IR, Lee SW, Jones M, Loewendorf A, Gostick E, Price DA, Benedict CA, Ware CF, Croft M: Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol 2010, 40:2762-2768.
44. Waller EC, McKinney N, Hicks R, Carmichael AJ, Sissons JG, Wills MR: Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(S) CD45RA(HI)) CD8(+) T cells. Blood 2007, 110:4360-4366. (Pubitemid 351377801)
45. Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang PA, Ambagala T, Pellegrini M, Calzascia T, Aidarus N et al.: Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J Exp Med 2012, 209:77-91.
46. Salek-Ardakani S, Arens R, Flynn R, Sette A, Schoenberger SP, Croft M: Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol 2009, 182:2909-2918.
47. Vidric M, Suh WK, Dianzani U, Mak TW, Watts TH: Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice. J Immunol 2005, 175:7288-7296. (Pubitemid 41713424)
48. Verweij CL, Geerts M, Aarden LA: Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J Biol Chem 1991, 266:14179-14182. (Pubitemid 21907480)
49. Peperzak V, Xiao Y, Veraar EA, Borst J: CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 2010, 120:168-178.
50. Arens R: Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors. Adv Immunol 2012, 114:217-243.
51. Benedict CA, Loewendorf A, Garcia Z, Blazar BR, Janssen EM: Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J Immunol 2008, 180:4836-4847.
52. Coscoy L, Ganem D: A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 2001, 107:1599-1606. (Pubitemid 32574646)
53. Chaudhry A, Das SR, Hussain A, Mayor S, George A, Bal V, Jameel S, Rath S: The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 2005, 175:4566-4574. (Pubitemid 41361995)
54. Loewendorf AI, Steinbrueck L, Peter C, Busche A, Benedict CA, Kay-Jackson PC: The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses. J Virol 2011, 85:5208-5212.
55. Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemcovicova I, Wang EC, Stanton RJ, Macauley M, Norris P, Willen L et al.: Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe 2013, 13:324-335.
56. Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T, Yamanishi K, Mori Y: CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci USA 2013, 110:9096-9099.
57. Croft M, Benedict CA, Ware CF: Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov 2013, 12:147-168.
58. Salek-Ardakani S, Moutaftsi M, Sette A, Croft M: Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection. J Virol 2011, 85:9051-9059.
59. Zhao Y, Tahiliani V, Salek-Ardakani S, Croft M: Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens. Front Immunol 2012, 3:332.
60. Lee SW, Salek-Ardakani S, Mittler RS, Croft M: Hypercostimulation through 4-1BB distorts homeostasis of immune cells. J Immunol 2009, 182:6753-6762.
61. Zhang B, Maris CH, Foell J, Whitmire J, Niu L, Song J, Kwon BS, Vella AT, Ahmed R, Jacob J, Mittler RS: Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 2007, 117:3029-3041. (Pubitemid 47529632)
62. Kim HS, Kim-Schulze S, Kim DW, Kaufman HL: Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1BB ligand. Cancer Res 2009, 69:8516-8525.
63. Feder-Mengus C, Schultz-Thater E, Oertli D, Marti WR, Heberer M, Spagnoli GC, Zajac P: Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses. Hum Gene Ther 2005, 16:348-360. (Pubitemid 40471895)
64. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne- Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T et al.: Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011, 473:523-527.
65. Ariotti S, Beltman JB, Chodaczek G, Hoekstra ME, van Beek AE, Gomez-Eerland R, Ritsma L, van RJ, Maree AF, Zal T et al.: Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc Natl Acad Sci USA 2012, 109:19739-19744.
66. Shin H, Iwasaki A: A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012, 491:463-467.
67. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF: Programming for CD8 T cell memory development requires IL- 12 or type I IFN. J Immunol 2009, 182:2786-2794.
68. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K: Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 2006, 177:1746-1754. (Pubitemid 44092511)
69. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F, Trinchieri G, Biron CA: Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 2002, 195:517-528. (Pubitemid 34461304)
70. Ballesteros-Tato A, Leon B, Lund FE, Randall TD: Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010, 11:216-224.